Signalling pathways of the TNF superfamily: a double-edged sword

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

An endotoxin-induced serum factor that causes necrosis of tumors

Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532

The Fas Death Factor

Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979

The TNF and TNF Receptor Superfamilies

Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.

Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351

A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149

Identification and characterization of a new member of the TNF family that induces apoptosis

Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,736

NF-κB at the crossroads of life and death

Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709

Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483

Tumor necrosis factor signaling

Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,422

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290

Protection from obesity-induced insulin resistance in mice lacking TNF-α function

Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 1,990

TNF-R1 Signaling: A Beautiful Pathway

Chen, G., & Goeddel, D. V. (2002) · Science · doi:10.1126/science.1071924 · Cited by 1,930

The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death

Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909

Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family

Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,777

The Receptor for the Cytotoxic Ligand TRAIL

Pan, G., O’Rourke, K. M., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,755

Signal transduction by tumor necrosis factor and its relatives.

Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,741

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,732

Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro

Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,572

Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes

McDermott, M., Aksentijevich, I. A., Galon, J., McDermott, E. M., Ogunkolade, B.-W., Centola, M. B., Mansfield, E. A., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,404

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Yonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,398

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

Ashkenazi, A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc821 · Cited by 1,351

BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

Schneider, P., Mackay, F., Steiner, V., Hofmann, K., Bodmer, J.-L., Holler, N., Ambrose, C. M., Lawton, P., Bixler, S. A., Acha‐Orbea, H., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1747 · Cited by 1,334

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

Grell, M., Douni, E. K., Wajant, H., Löhden, M., Clauss, M. A., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G. A., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,328

A novel domain within the 55 kd TNF receptor signals cell death

Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290

MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1

Malinin, N. L., Boldin, M., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,279

Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?

Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,252

Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Hotamışlıgil, G. S., Murray, D. L., Choy, L., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,220

Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative Disease

Cohen, P. L., & Eisenberg, R. A. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001331 · Cited by 1,169

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J. C., Ulevitch, R. J., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,132

The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal

Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., & Leder, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80535-x · Cited by 1,102

BAFF and APRIL: A Tutorial on B Cell Survival

Mackay, F., Schneider, P., Rennert, P. D., & Browning, J. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141152 · Cited by 1,004

Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5

Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975

The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways

Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z., Karin, M., Ware, C. F., & Green, D. R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00423-5 · Cited by 923

Human tumor necrosis factor. Production, purification, and characterization.

Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 917

Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon

Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 876

A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling

Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H.-L., Steinman, R. M., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2075 · Cited by 853

A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen

Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 845

Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis

Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839

Early Lethality, Functional NF-κB Activation, and Increased Sensitivity to TNF-Induced Cell Death in TRAF2-Deficient Mice

Yeh, W., Shahinian, A., Speiser, D. E., Kraunus, J., Billia, F., Wakeham, A. C., de la Pompa, J. L., Ferrick, D. A., Hum, B., Iscove, N. N., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80391-x · Cited by 798

Fas Ligand-Induced Apoptosis

Nagata, S. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.29 · Cited by 777

The osteoclast differentiation factor osteoprotegerin ligand is essential for mammary gland development.

Fata, J. E., Kong, Y.-Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00103-3 · Cited by 756

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

Gardam, M. A., Keystone, E. C., Menzies, R., Manners, S., Skamene, E., Long, R., & Vinh, D. C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00545-0 · Cited by 742

CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA

COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 717

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

Chun, H. J., Zheng, L., Ahmad, M., Wang, J., Speirs, C. K., Siegel, R. M., Dale, J. K., Puck, J. M., Davis, J., Hall, C. G., et al. (2002) · Nature · doi:10.1038/nature01063 · Cited by 706

TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB

Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 697

BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells

Claudio, E., Brown, K., Park, S., Wang, H., & Siebenlist, U. K. (2002) · Nature Immunology · doi:10.1038/ni842 · Cited by 694

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarrett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., et al. (1984) · Nature · doi:10.1038/312721a0 · Cited by 641

TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell Costimulator

Migone, T., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S.-F., Zhou, J. X. H., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00283-2 · Cited by 637

Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice

Cretney, E., Takeda, K., Yagita∥, H., Glaccum, M. B., Peschon, J. J., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1356 · Cited by 615

Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and deathPreprint

Arch, R. H., Gedrich, R. W., & Thompson, C. B. (1998) · Genes & Development · doi:10.1101/gad.12.18.2821 · Cited by 611

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing

Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 558

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 544

NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia

Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., Macpherson, H. K., Wallace, R. G. H., Hul, W. V., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 484

IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development

Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R. S., Schmidt, E. V., & Karin, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00599-2 · Cited by 479

BAFF/BLyS Receptor 3 Binds the B Cell Survival Factor BAFF Ligand through a Discrete Surface Loop and Promotes Processing of NF-κB2

Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W. P., French, D. M., Grewal, I. S., Cochran, A. G., Gordon, N. C., Yin, J., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00425-9 · Cited by 476

Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation

Legler, D. F., Micheau, O., Doucey, M., Tschopp, J., & Bron, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00092-x · Cited by 473

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

Straus, S. E. (2001) · Blood · doi:10.1182/blood.v98.1.194 · Cited by 464

TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2

Li, X., Yang, Y., & Ashwell, J. D. (2002) · Nature · doi:10.1038/416345a · Cited by 452

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Williamson, B., Carswell, E. A., Rubin, B. Y., Prendergast, J., & Old, L. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5397 · Cited by 451

SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice

Emanuelli, B., Peraldi, P., Filloux, C., Carine Chavey, A., Freidinger, K., Hilton, D. J., Hotamışlıgil, G. S., & OBBERGHEN, E. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104602200 · Cited by 449

Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety

Kelley, S. K., Harris, L. A., Xie, D., DeForge, L. E., Tótpál, K., Bussiere, J., & Fox, J. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29298-3 · Cited by 444

The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis

Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M. R., & Matrisian, L. M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80113-x · Cited by 421

A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis

Nocentini, G., Giunchi, L., Ronchetti, S., Krausz, L. T., Bartoli, A., Moraca, R., Migliorati, G., & Riccardi, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6216 · Cited by 412

Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival

Lum, L., Wong, B. R., Josien, R., Becherer, J. D., Erdjument‐Bromage, H., Schlöndorff, J. S., Tempst, P., Choi, Y., & Blobel, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13613 · Cited by 412

Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice

Li, Y., Wu, L., Wesche, H., Arthur, C. D., White, J. M., Goeddel, D. V., & Schreiber, R. D. (2001) · Science · doi:10.1126/science.1058453 · Cited by 408

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

Suenaert, P., Bulteel, V., Lemmens, L., Noman, M., Geypens, B. J., Assche, G. V., Geboes, K. J., Ceuppens, J. L., & Rutgeerts, P. J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05914.x · Cited by 402

Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing Kinase

Darnay, B. G., Ni, J., Moore, P. A., & Aggarwal, B. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7724 · Cited by 399

Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis

Romas, E., Gillespie, M., & Martin, T. (2002) · Bone · doi:10.1016/s8756-3282(01)00682-2 · Cited by 390

CRINKLY4: A TNFR-Like Receptor Kinase Involved in Maize Epidermal Differentiation

Becraft, P. W., Stinard, P. S., & McCarty, D. R. (1996) · Science · doi:10.1126/science.273.5280.1406 · Cited by 386

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression

Song, K., Chen, Y., Göke, R., Wilmen, A., Seidel, C., Göke, A., Hilliard, B. A., & Chen, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1095 · Cited by 361

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice

Lamhamedi-Cherradi, S.-E., Zheng, S. J., Maguschak, K. A., Peschon, J. J., & Chen, Y. H. (2003) · Nature Immunology · doi:10.1038/ni894 · Cited by 350

Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase

Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G.-L., & Aggarwal, B. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15978 · Cited by 319

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB

Ravi, R. K., Bedi, G. C., Engstrom, L., Zeng, Q., Mookerjee, B., Gélinas, C., Fuchs, E. J., & Bedi, A. (2001) · Nature Cell Biology · doi:10.1038/35070096 · Cited by 316

Critical Roles of TRAF2 and TRAF5 in Tumor Necrosis Factor-induced NF-κB Activation and Protection from Cell Death

Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T. W., Yagita, H., Okumura, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104837200 · Cited by 306

Identification and functional characterization of DR6, a novel death domain‐containing TNF receptor

Pan, G., Bauer, J. H., Haridas, V., Wang, S., Ding, L., Yu, G., Vincenz, C., Aggarwal, B. B., Ni, J., & Dixit, V. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00791-1 · Cited by 292

Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.

Aggarwal, B. B., Moffat, B., & Harkins, R. N. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43716-1 · Cited by 290

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF

Grell, M., Zimmermann, G., Gottfried, E., Chen, C., Grünwald, U., Huang, D. C. S., Lee, Y. W., Dürkop, H., Engelmann, H., Scheurich, P., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3034 · Cited by 284

Mekk3 is essential for early embryonic cardiovascular development

Yang, J., Boerm, M., McCarty, M. F., BUCANA, C. D., Fidler, I. J., Yang, Y. Z. J., & Su, B. (2000) · Nature Genetics · doi:10.1038/73550 · Cited by 244

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

Eggermont, A. M. M., de Wilt, J. H., & ten Hagen, T. L. M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01141-0 · Cited by 236

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

Feinberg, B. A., Kurzrock, R., Talpaz, M., Blick, M. B., Saks, S. R., & Gutterman, J. U. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.8.1328 · Cited by 221

Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis

Harper, N. W., Hughes, M. A., MacFarlane, M., & Cohen, G. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303399200 · Cited by 209

Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4

Chuntharapai, A., Dodge, K., Grimmer, K., Schroeder, K. A., Marsters, S. A., Koeppen, H., Ashkenazi, A., & Kim, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4891 · Cited by 203

Identity of differentiation inducing factor and tumour necrosis factor

Takeda, K., Iwamoto, S., Sugimoto, H., Takuma, T., Kawatani, N., Noda, M., Masaki, A., Morise, H., Arimura, H., & Konno, K. (1986) · Nature · doi:10.1038/323338a0 · Cited by 182

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

Kwon, B. S., Wang, S., Udagawa, N., Haridas, V., Lee, Z. H., Kim, K. K., Oh, K., Greene, J., Li, Y., Su, J. Y., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.845 · Cited by 179

Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line.

Aggarwal, B. B., Henzel, W. J., Moffat, B., Kohr, W. J., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89559-x · Cited by 170

Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy

Wielockx, B., Lannoy, K., Shapiro, S. D., Itoh, T., Itohara, S., Vandekerckhove, J. S., & Libert, C. (2001) · Nature Medicine · doi:10.1038/nm1101-1202 · Cited by 166

Chemical Treatment of Tumors. V. Isolation of the Hemorrhage-Producing Fraction from Serratia marcescens (Bacillus prodigiosus) Culture Filtrate 1

Shear, M. J., Turner, F. C., Perrault, A., & Shovelton, T. (1943) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/4.1.81 · Cited by 163

A Role for Fas in Negative Selection of Thymocytes In Vivo

Kishimoto, H., Surh, C. D., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1427 · Cited by 161

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

Zhai, Y., Ni, J., Jiang, G., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F., KOZAK, D., XU, S., et al. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.181 · Cited by 159

Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.

Fisher, M. J., Virmani, A. K., Wu, L., Aplenc, R., Harper, J. C., Powell, S. M., Rebbeck, T. R., Sidransky, D., Gazdar, A. F., & El‐Deiry, W. S. (2001) · PubMed · Cited by 143

TNFR80-Dependent Enhancement of TNFR60-Induced Cell Death Is Mediated by TNFR-Associated Factor 2 and Is Specific for TNFR60

Weiß, T., Grell, M., Siemienski, K., Mühlenbeck, F., Dürkop, H., Pfizenmaier, K., Scheurich, P., & Wajant, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3136 · Cited by 134

Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia

Chen, Y., Molloy, S. S., Thomas, L., Gambee, J. E., Bächinger, H. P., Ferguson, B. M., Zonana, J., Thomas, G., & Morris, N. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131076098 · Cited by 124

NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death

Zheng, Y., Ouaaz, F., Bruzzo, P., Singh, V., Gerondakis, S., & Beg, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4949 · Cited by 117

Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation

Klefström, J. T., Arighi, E., Littlewood, T., Jäättelä, M., Saksela, E., Evan, G. I., & Alitalo, K. K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7382 · Cited by 117

Lymphocyte in vitro Cytotoxicity: Lymphotoxins of Several Mammalian Species

Williams, T. W., & Granger, G. A. (1968) · Nature · doi:10.1038/2191076a0 · Cited by 115

Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model

Nagata, S. (1998) · Journal of Human Genetics · doi:10.1007/s100380050029 · Cited by 97

Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB

Kasof, G. M., Lu, J. J., Liu, D., Speer, B. S., Mongan, K. N., Gomes, B. C., & Lorenzi, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204985 · Cited by 96

Inflammatory Mediators and the Failing Heart: A Translational Approach

Diwan, A., Tran, T. T., Misra, A., & Mann, D. L. (2003) · Current Molecular Medicine · doi:10.2174/1566524033361537 · Cited by 93

Tumour Necrosis Factor in Chronic Heart Failure

Bolger, A. P., & Anker, S. D. (2000) · Drugs · doi:10.2165/00003495-200060060-00002 · Cited by 86

Death Receptor Signaling Giving Life to Ectodermal Organs

Thesleff, I., & Mikkola, M. L. (2002) · Science Signaling · doi:10.1126/stke.2002.131.pe22 · Cited by 76

Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α

Lauzurica, P., Martı́nez-Martı́nez, S., Marazuela, M., Arco, P. G., Martínez‐A, C., Sánchez‐Madrid, F., & Redondo, J. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06 · Cited by 71

c-Myc Sensitizes Cells to Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Nuclear Factor κB Transactivation

You, Z., Madrid, L. V., Saims, D., Sedivy, J. M., & Wang, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203213200 · Cited by 70

Action of Bacterial Polysaccharide on Tumors. II. Damage of Sarcoma 37 by Serum of Mice Treated With Serratia Marcescens Polysaccharide, and Induced Tolerance

O'Malley, W. E., Achinstein, B., & Shear, M. J. (1962) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/29.6.1169 · Cited by 68

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

Couriel, D. R., Hicks, K. L., Giralt, S. A., & Champlin, R. E. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00011 · Cited by 65

VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth

Haridas, V., Shrivastava, A., Su, J. Y., Yu, G.-L., Ni, J., Liu, D., Chen, S.-F., Ni, Y., Ruben, S. M., Gentz, R., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1203059 · Cited by 60

Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Abrogates Ligand-mediated Activation of Nuclear Factor-κB and of Mitogen-activated Protein Kinases in Macrophages

Mukhopadhyay, A., Suttles, J., Stout, R. D., & Aggarwal, B. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105252200 · Cited by 60

The Role of TNF Receptor and TNF Superfamily Molecules in Organ Transplantation

Adams, A. B., Larsen, C. P., Pearson, T. C., & Newell, K. A. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.020104.x · Cited by 53

Vascular Reactions of Normal and Malignant Tissues in Vivo. V. The Rôle of Hypotension in the Action of a Bacterial Polysaccharide on Tumors

Algire, G. H., Legallais, F. Y., & ANDERSON, B. F. (1952) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/12.6.1279 · Cited by 47

Role of Defective Apoptosis in Type 1 Diabetes and Other Autoimmune Diseases

Hayashi, T. (2003) · Recent Progress in Hormone Research · doi:10.1210/rp.58.1.131 · Cited by 45

Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance

Aganna, E., Aksentijevich, I. A., Hitman, G. A., Kastner, D. L., Hoepelman, A. I. M., Posma, F. D., Ej, Z., & McDermott, M. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200573 · Cited by 45

Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion.

Lans, T. E., Bartlett, D. L., Libutti, S. K., Gnant, M., Liewehr, D. J., Venzon, D. J., Turner, E. M., & Alexander, H. R. (2001) · PubMed · Cited by 45

Frequent mutations of Fas gene in thyroid lymphoma.

Takakuwa, T., Dong, Z., Takayama, H., Matsuzuka, F., Nagata, S., & Aozasa, K. (2001) · PubMed · Cited by 44

Fas Gene Mutations in Prostatic Intraepithelial Neoplasia and Concurrent Carcinoma: Analysis of Laser Capture Microdissected Specimens

Takayama, H., Takakuwa, T., Dong, Z., Nonomura, N., Okuyama, Ä., Nagata, S., & Aozasa, K. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780236 · Cited by 35

Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-κB, Mitogen-activated Protein Kinases, and Apoptosis

Takada, Y., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213237200 · Cited by 35

ACTION OF BACTERIAL POLYSACCHARIDE ON TUMORS. III. REPEATED RESPONSE OF SARCOMA 37, IN TOLERANT MICE, TO SERRATIA MARCESCENS ENDOTOXIN.

O'Malley, W. E., Achinstein, B., & Shear, M. J. (1963) · PubMed · Cited by 28

Frequent Fas Gene Mutations in Testicular Germ Cell Tumors

Takayama, H., Takakuwa, T., Tsujimoto, Y., Tani, Y., Nonomura, N., Okuyama, Ä., Nagata, S., & Aozasa, K. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64219-8 · Cited by 28

CD40—CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1)

Ramesh, N., Morio, T., Fuleihan, R., Worm, M., Horner, A. A., Tsitsikov, E. N., Castigli, E., & Geha, R. S. (1995) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(95)90252-x · Cited by 24

Structural and Biochemical Analysis of Signal Transduction by the TRAF Family of Adapter ProteinsPreprint

McWhirter, S. M., Pullen, S. S., WERNEBURG, B. G., Labadia, M. E., Ingraham, R. H., Crute, J. J., Kehry, M. R., & Alber, T. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.551 · Cited by 13

Signaling to NF-κB

Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Aggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,043

Into the Eye of the Cytokine Storm

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940

Tumour necrosis factor and cancer

Balkwill, F. R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2628 · Cited by 1,976

Molecular targets of dietary agents for prevention and therapy of cancer

Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,774

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily

Gaur, U., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00490-8 · Cited by 556

Overview of TNF Superfamily: A Chest Full of Potential Therapeutic Targets

Grewal, I. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_1 · Cited by 53

Review article Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2016)

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877

The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion

Aggarwal, B. B., Shishodia, S., Ashikawa, K., & Bharti, A. C. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344571 · Cited by 131